COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD ZincZn
HC Q study #60
Source   PDF   Share   Tweet
See all 155 studies
6/18
Inconc.
Late treatment study
Paccoud et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaa791 (Peer Reviewed)
Compassionate use of hydroxych loroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital
Retrospective of 89 hospitalized patients, survival HR 0.89 [0.23-3.47], not statistically significant. Authors note that unmeasured confounders may have persisted and the study may be underpowered.
death, ↓11.0%, p=0.88
Source   PDF   Share   Tweet
See all 155 studies
Please send us corrections, updates, or comments.
Submit